Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Coherus BioSciences
Coherus BioSciences
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Loqtorzi
Toripalimab
2023-10-27
Nasopharyngeal carcinoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Toripalimab
neoplasms
,
non-small-cell lung carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
Zimberelimab
prostatic neoplasms
,
castration-resistant prostatic neoplasms
Gilvetmab
lung neoplasms
,
small cell lung carcinoma
,
neoplasms
,
melanoma
,
urinary bladder neoplasms
,
esophageal squamous cell carcinoma
,
triple negative breast neoplasms
,
malignant mesothelioma
,
breast neoplasms
,
glioblastoma
,
colorectal neoplasms
,
pancreatic neoplasms
,
neoplasm metastasis
,
tumor virus infections
,
non-small-cell lung carcinoma
Aglatimagene besadenovec
prostatic hyperplasia
,
alopecia areata
,
alopecia
,
hyperplasia
ETRUMADENANT
prostatic neoplasms
,
castration-resistant prostatic neoplasms
Globulin, immune
colorectal neoplasms
,
lung neoplasms
,
non-small-cell lung carcinoma
,
breast neoplasms
,
neoplasms
,
urinary bladder neoplasms
,
kidney neoplasms
,
ovarian neoplasms
,
neoplasm metastasis
,
recurrence
,
squamous cell carcinoma of head and neck
,
prostatic neoplasms
,
ovarian epithelial carcinoma
,
adenocarcinoma
,
head and neck neoplasms
,
rheumatoid arthritis
,
polyomavirus infections
,
glioblastoma
,
endometrial neoplasms
,
merkel cell carcinoma
,
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use